Skip to main content
Full access
Brief Report
Published Online: 1 September 2002

Paternal Age and Schizophrenia: Further Support for an Association

Publication: American Journal of Psychiatry

Abstract

OBJECTIVE: Advanced paternal age has been proposed as a risk factor for later development of schizophrenia in offspring, although studies are not conclusive. De novo mutations arising in paternal germ cells have been suggested as the underlying mechanism. METHOD: The hypothesized association was investigated in a population-based case-control study comprising 524 subjects with schizophrenia and 1,043 matched comparison subjects selected from registers. Birth records with data on parental age were retrieved manually. Odds ratios were computed, with controls for maternal age, parity, marital status, socioeconomic status, maternal psychotic illness, and obstetric complications. RESULTS: The odds of schizophrenia in offspring of fathers 45 years old or older were 2.8 times as great as in offspring of fathers aged 20–24 years. CONCLUSIONS: These findings confirm previous reports of a higher risk for schizophrenia associated with advanced paternal age. They may be of interest for further studies on the genetic mechanisms behind schizophrenia.
Advanced paternal age has been proposed as a risk factor for the later development of schizophrenia in the offspring (1, 2). However, one study in which social factors were taken into account did not show such an association (3). Recently, in a methodologically stronger study of a birth cohort from Jerusalem (4), a higher risk for schizophrenia among subjects with older fathers was once again shown. De novo mutations arising in paternal germ cells were suggested as the underlying mechanism. The study included 658 cases of schizophrenia and related nonaffective psychosis (ICD-10 codes F20–F29) from the psychiatric registry. Unfortunately, there was no information available on the validity of the diagnoses or on the proportion of subjects with schizophrenia. In the Swedish inpatient register, cases of broad schizophrenia (ICD-9 code 295) constitute approximately 55%–60% of the treated patients with those diagnoses. In this article we present the results from a population-based case-control study including 524 cases of broad schizophrenia in which we were able to take several possible confounding factors into account.

Method

We used the Stockholm County inpatient register (5) to identify all people born in Stockholm during 1960–1977 who had received a diagnosis of schizophrenia syndrome (ICD-8 and ICD-9 code 295, corresponding to ICD-10 codes F20, F21, F23.1–F23.2, F25) between 1971 and 1994 (N=648). Deceased individuals (N=51) and those who did not reside in Stockholm (N=32) were excluded. The parishes of birth of the remaining 565 subjects were obtained from taxation offices, and the birth hospitals were then located; 37 (6.5%) of the birth records could not be retrieved.
Each of the subjects with schizophrenia was matched with two subjects from the parish register who 1) were born immediately after the subject with schizophrenia, 2) were matched for sex and hospital of birth, and 3) resided in Stockholm at the time the cases were selected. For 87 (7.7%) of the 1,130 matched comparison subjects, birth records could not be retrieved. Four subjects with schizophrenia lacked comparison subjects because of the low number of births in the parish, and they were excluded, leaving 524 subjects with schizophrenia and 1,043 comparison subjects.
The records contain information on parental date of birth, occupation, marital status, and obstetric complications. The 1,567 birth records were copied in the archives and given code numbers to conceal each subject’s status (schizophrenia or comparison). The records were randomly assembled and given in batches to a midwife, who extracted data according to a protocol.
A socioeconomic index (6) was estimated from data on parental occupation and was based on the highest socioeconomic status in the family: group I (socioeconomic index 54–87) included upper-level executives and the self-employed, group II (socioeconomic index 33–47) included assistant nonmanual employees, and group III (socioeconomic index 11–22) included unskilled and skilled employees in goods and service production.
Through a linkage with the national inpatient register, we identified mothers who had been admitted to hospitals during 1971–1996 with psychotic illness (ICD-8 codes 295–299, ICD-9 codes 295–298).
Odds ratios and 95% confidence intervals (CIs) for schizophrenia in relation to paternal age were calculated by using conditional logistic regression and were adjusted for possible confounders, i.e., maternal age (<20, 20–24, 25–39, ≥40 years), parity (1, 2 or 3, ≥4), marital status (married, unmarried, or divorced), socioeconomic index, maternal psychotic illness, and any of the following obstetric complications: preeclampsia, gestational age <33 weeks, small for gestational age, signs of asphyxia (complications expected to yield an Apgar score less than 7 at 1, 5, or 10 minutes), and hyperbilirubinemia (>15 mg/dl).

Results

There was information about paternal age in the birth records of 420 (80.2%) of the 524 subjects with schizophrenia and 857 (82.2%) of the 1,043 comparison subjects. Thus, the distribution of dropouts was even.
There was an increased risk of schizophrenia associated with advanced paternal age (Table 1). Having a father aged 45 years or older was associated with a doubled risk for schizophrenia. Since the age of the father is expected to be associated with the age of the mother, we adjusted for this factor, which increased the odds ratio to 2.8. Finally, we also adjusted for parity, social factors, maternal psychotic illness, and obstetric complications. This procedure did not substantially alter the results.
Higher or lower maternal age was not associated with increased risk for schizophrenia; for mothers 40 years old or older the odds ratio was 0.6 (95% CI=0.2–1.7), and for those younger than 20 years the odds ratio was 1.2 (95% CI=0.7–2.2).

Discussion

This study confirms the results from the Jerusalem study (4). Thus, there seems to be an association between advanced paternal age and the later development of schizophrenia. There was no association with greater maternal age. After adjustments for maternal age, the risk estimates increased, which indicates that the father’s age is the factor of interest in this study, not maternal age. The association was not affected when we controlled for social factors or obstetric complications.
In this study we investigated the impact of paternal age in a large sample of persons with schizophrenia. The information was collected at birth without knowledge of future disease status, thus decreasing the risk of bias. The diagnoses of the Stockholm inpatient register have been validated and proved to be of good quality. Approximately 80% of the ICD diagnoses in the register fulfilled the DSM criteria for schizophrenia (5). A limitation of the study is the lack of data on paternal psychiatric illness, which is a possible confounder. Another drawback is that 20% of the birth records lacked information on paternal age. The lack of information was evenly distributed among subjects with schizophrenia and comparison subjects, and we cannot find any reason to suspect any systematic bias regarding this factor, especially since social factors did not seem to have an impact on the results.
What are the possible underlying mechanisms? As proposed by Malaspina et al. (4), de novo mutations arising in paternal germ cells may be an explanation, since the rate of these mutations increases with advancing age and they have been shown to be related to disease (7, 8). Having an older father may be associated with early parental loss, which may be a risk factor for schizophrenia. On the other hand, this is to some extent contradicted by the fact that having an older mother was not associated with the risk of schizophrenia. There is also the possibility of a specific biological parental trait leading to delayed childbearing and schizophrenia.
In conclusion, our results support previous findings of an association between advanced paternal age and the risk of schizophrenia. The findings may be of interest for further studies on the genetic mechanisms behind schizophrenia.
TABLE 1

Footnote

Received Aug. 29, 2001; revision received April 9, 2002; accepted April 10, 2002. From Psychiatric Epidemiology–PEP, Stockholm Centre of Public Health; and the Department of Social Medicine, Göteborg University, Göteborg, Sweden. Address reprint requests to Dr. Dalman, Psychiatric Epidemiology–PEP, Stockholm Centre of Public Health, P.O. Box 175 33, S-118 91 Stockholm, Sweden; [email protected] (e-mail). Supported by the Stanley Foundation, the Söderberg Foundations, and the Söderberg-Königska Foundation. The authors thank Stefan Granbom for performing the statistical analyses and midwives Gunilla Lilja and Åsa Weitzberg for assessing records.

References

1.
Hare EH, Moran PA: Raised paternal age in psychiatric patients: evidence for the constitutional hypothesis. Br J Psychiatry 1979; 134:169-177
2.
Kinnell HG: Parental age in schizophrenia (letter). Br J Psychiatry 1983; 142:204
3.
Bertranpetit J, Fananas L: Parental age in schizophrenia in a case-controlled study (letter). Br J Psychiatry 1993; 162:574
4.
Malaspina D, Harlap S, Fennig S, Heiman D, Nahon D, Feldman D, Susser E: Advancing paternal age and the risk of schizophrenia. Arch Gen Psychiatry 2001; 58:361-367
5.
Kristjansson E, Allebeck P, Wistedt B: Validity of the diagnosis schizophrenia in a psychiatric inpatient register: a retrospective application of DSM-III criteria on ICD-8 diagnoses in Stockholm county. Nord Psyckiatr Tidsskr 1987; 41:229-234
6.
Ericson A, Eriksson M, Källen B, Zetterström R: Methods for the evaluation of social effects of birth weight: experiences with Swedish population registries. Scand J Soc Med 1993; 21:69-76
7.
Crow JF: The high spontaneous mutation rate: is it a health risk? Proc Natl Acad Sci USA 1997; 94:8380-8386
8.
Hemminki K, Kyyronen P: Parental age and risk of sporadic and familial cancer in offspring: implications for germ cell mutagenesis. Epidemiology 1999; 10:747-751

Information & Authors

Information

Published In

Go to American Journal of Psychiatry
Go to American Journal of Psychiatry
American Journal of Psychiatry
Pages: 1591 - 1592
PubMed: 12202282

History

Published online: 1 September 2002
Published in print: September 2002

Authors

Details

Christina Dalman, M.D., Ph.D.
Peter Allebeck, M.D., Ph.D.

Metrics & Citations

Metrics

Citations

Export Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click Download.

For more information or tips please see 'Downloading to a citation manager' in the Help menu.

Format
Citation style
Style
Copy to clipboard

View Options

View options

PDF/EPUB

View PDF/EPUB

Get Access

Login options

Already a subscriber? Access your subscription through your login credentials or your institution for full access to this article.

Personal login Institutional Login Open Athens login
Purchase Options

Purchase this article to access the full text.

PPV Articles - American Journal of Psychiatry

PPV Articles - American Journal of Psychiatry

Not a subscriber?

Subscribe Now / Learn More

PsychiatryOnline subscription options offer access to the DSM-5-TR® library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.

Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).

Media

Figures

Other

Tables

Share

Share

Share article link

Share